Forecasts data is unavailable for this security.
Consensus recommendation
- 16-Nov-23
- 15-Aug-24
- 19-Sep-24
- 17-Oct-24
- 07-Nov-24
Select bar for recommendation details.
Recommendations | 07-Nov-24 | |
---|---|---|
Buy | 5 | |
Outperform | 6 | |
Hold | 1 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 9 analysts offering 12 month price targets for Janux Therapeutics Inc have a median target of 70.00, with a high estimate of 100.00 and a low estimate of 42.00. The median estimate represents a 32.48% increase from the last price of 52.84.
High | 89.3% | 100.00 |
Med | 32.5% | 70.00 |
Low | -20.5% | 42.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Mar 11, 2025.
Average growth rate | -80.08% |
Average growth rate | +1.90% |
More ▼
Revenue history & estimates in USD
Average growth rate | +116.05% |
Average growth rate | +65.32% |
More ▼